ArrowMark Colorado Holdings’s Pliant Therapeutics PLRX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354K	Hold	281,189	–	–	0.01%	276
2025 Q4	$343K	Hold	281,189	–	–	0.01%	294
2025 Q3	$416K	Hold	281,189	–	–	0.01%	285
2025 Q2	$326K	Hold	281,189	–	–	0.01%	287
2025 Q1	$380K	Hold	281,189	–	–	0.01%	277
2024 Q4	$3.7M	Hold	281,189	–	–	0.05%	210
2024 Q3	$3.15M	Hold	281,189	–	–	0.04%	210
2024 Q2	$3.02M	Hold	281,189	–	–	0.04%	229
2024 Q1	$4.19M	Hold	281,189	–	–	0.05%	220
2023 Q4	$5.09M	Hold	281,189	–	–	0.06%	202
2023 Q3	$4.88M	Hold	281,189	–	–	0.06%	194
2023 Q2	$5.1M	Buy	+281,189	New	+$6.66M	0.06%	198

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

ArrowMark Colorado Holdings's PLRX Position: Q1 2026 in Review

ArrowMark Colorado Holdings held its Pliant Therapeutics (PLRX) position steady in Q1 2026 at 281,189 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #276.

ArrowMark Colorado Holdings first reported a position in PLRX in Q2 2023 and has held it in 12 quarters since. The position peaked at $5.1M in Q2 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

ArrowMark Colorado Holdings held 281,189 shares of Pliant Therapeutics worth $354K as of Q1 2026.
ArrowMark Colorado Holdings left its Pliant Therapeutics share count unchanged in Q1 2026.
Pliant Therapeutics made up 0.01% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #276 holding.
ArrowMark Colorado Holdings first reported a position in Pliant Therapeutics in Q2 2023 and has held it in 12 quarters since.
ArrowMark Colorado Holdings's Pliant Therapeutics position peaked at $5.1M in Q2 2023.
91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.